Trade KTTAW anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Pasithea Therapeutics Corp. Warrant (KTTAW) is trading at US$0.01, up 0.00% today as of Sep 4, 16:00 EDT. Over the past 52 weeks, KTTAW has traded between US$0.00 and US$0.12. On Syfe you can trade KTTAW with $0 commission and add it to your watchlist.
| Previous close | US$0.01 |
|---|---|
| 52-week range | US$0.00 – US$0.12 |
| Volume | 10.9K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Pasithea Therapeutics Corp. Warrant
Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.
Year: 2021
Pasithea Therapeutics Corp. Warrant (KTTAW) stock is trading at US$0.01, 0.00% from the previous close of US$0.01.
The 52-week high for Pasithea Therapeutics Corp. Warrant (KTTAW) stock is US$0.12.
The 52-week low for Pasithea Therapeutics Corp. Warrant (KTTAW) stock is US$0.00.
Pasithea Therapeutics Corp. Warrant (KTTAW) does not currently pay a dividend.
Stay on top of KTTAW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
